Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)
Close on Nov 17, 2026Market cap $249.12MP/E –Yield –
Amarin price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Amarin's price to book ratio was 0.6× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.4× to 2.2×, with a median of 0.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −0.1 |
| 2025 | Dec 31, 2025 | 0.6× | +0.3 |
| 2024 | Dec 31, 2024 | 0.4× | −0.3 |
| 2023 | Dec 29, 2023 | 0.6× | −0.2 |
| 2022 | Dec 30, 2022 | 0.8× | −1.2 |
| 2021 | Dec 31, 2021 | 2.1× | −1.1 |
| 2020 | Dec 31, 2020 | 3.1× | −9.7 |
| 2019 | Dec 31, 2019 | 12.9× | −39.8 |
| 2017 | Jan 31, 2017 | 52.7× | −2.0 |
| 2016 | Dec 30, 2016 | 54.6× | −273.3 |
| 2012 | Oct 31, 2012 | 328.0× | – |
See a number that looks wrong?